Moreover, genetic variants of SPP1 have been significantly linked to susceptibility and clinical severity in autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), underscoring its potential as a biomarker for irAEs (21). This evidence concerns the gene SPP1 and autoimmune disease.